Autophagy-Induced Nanoparticle-Based Clearing of Toxic Huntingtin Protein Aggregates from Neuron Cells
Source abstract
Abstract
Clearing of toxic huntingtin protein aggregates from neuron cells is critical for treatment of Huntington’s disease. However, this is very challenging and requires the control of intracellular processes and associated biochemical activities. Here, we report the designed nanoparticle-based clearing of toxic huntingtin protein aggregates via cellular autophagy induction. We have designed five different nanoparticles of 15–40 nm size that are composed of an iron oxide/zinc oxide/carbon core and a surface terminated with hemin/amine/arginine/trehalose. These nanoparticles induce cellular autophagy by three different mechanisms, and all of them clear toxic huntingtin aggregates from neuron cells. Such clearance of huntingtin aggregates by nanoparticles has shown a substantial increase in cell viability typically up to 7-fold. Our result suggests that autophagy-inducing nanodrugs may be designed for clearing toxic amyloid aggregates from the brain and treatment of neurodegenerative diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Genetic Neurodegenerative Diseases · Autophagy in Disease and Therapy · Neurological disorders and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Materials Sciences, Indian Association for the Cultivation of Science, Kolkata 700032, India
Cellular and Molecular Neuroscience, National Brain Research Centre, Haryana 122052, India
School of Bioscience, Indian Institute of Technology, Kharagpur 721302, India
Funding
Council of Scientific and Industrial Research, India · Department of Science and Technology, Ministry of Science and Technology, India
References (54)
Show source-provided references
1. 10.1038/nj7526-299a10.1038/nj7526-299a ↗
2. 10.1007/s00401-017-1709-710.1007/s00401-017-1709-7 ↗
3. 10.3233/JAD-2011-11018210.3233/JAD-2011-110182 ↗
4. 10.3389/fnagi.2020.0026110.3389/fnagi.2020.00261 ↗
5. 10.2174/1570159X1866620072911174410.2174/1570159X18666200729111744 ↗
6. 10.1002/cmdc.20070014010.1002/cmdc.200700140 ↗
7. 10.1002/smll.20200280410.1002/smll.202002804 ↗
8. 10.1155/2020/353457010.1155/2020/3534570 ↗
9. 10.3390/molecules2418337210.3390/molecules24183372 ↗
10. 10.1021/cr400372p10.1021/cr400372p ↗
11. 10.1007/BF0340204010.1007/BF03402040 ↗
12. 10.1038/nm.323210.1038/nm.3232 ↗
13. 10.3390/cells911239910.3390/cells9112399 ↗
14. 10.1002/adma.20140592610.1002/adma.201405926 ↗
15. 10.1016/j.ijpharm.2011.11.02010.1016/j.ijpharm.2011.11.020 ↗
16. 10.1021/acsabm.9b0051810.1021/acsabm.9b00518 ↗
17. 10.1021/mp500042310.1021/mp5000423 ↗
18. 10.1021/acs.chemmater.1c0194710.1021/acs.chemmater.1c01947 ↗
19. 10.1021/acsami.6b1154910.1021/acsami.6b11549 ↗
20. 10.1016/j.msec.2014.03.01110.1016/j.msec.2014.03.011 ↗
21. 10.1039/C8NR05770B10.1039/C8NR05770B ↗
22. 10.1038/s41467-022-33044-y10.1038/s41467-022-33044-y ↗
23. 10.1073/pnas.220036311910.1073/pnas.2200363119 ↗
24. Noor N. A. · Int. J. Sci.: Basic Appl. Res. · 2016 · 30 · 114
25. 10.1166/jnn.2015.961210.1166/jnn.2015.9612 ↗
26. 10.1016/j.ceramint.2013.02.02610.1016/j.ceramint.2013.02.026 ↗
27. 10.1039/C9NR03756J10.1039/C9NR03756J ↗
28. 10.1371/journal.pone.013472210.1371/journal.pone.0134722 ↗
29. 10.1021/acsami.7b0188610.1021/acsami.7b01886 ↗
30. 10.1021/acsbiomaterials.8b0119610.1021/acsbiomaterials.8b01196 ↗
31. 10.1039/D2NJ02966A10.1039/D2NJ02966A ↗
32. 10.1039/D2CP00301E10.1039/D2CP00301E ↗
33. 10.1021/acsami.3c0924110.1021/acsami.3c09241 ↗
34. 10.1042/BSR2018115610.1042/BSR20181156 ↗
35. 10.1098/rsob.17027110.1098/rsob.170271 ↗
36. 10.4161/auto.2131510.4161/auto.21315 ↗
37. 10.1002/jcp.2658310.1002/jcp.26583 ↗
38. 10.1021/acsabm.8b0061710.1021/acsabm.8b00617 ↗
39. 10.1042/bj057050810.1042/bj0570508 ↗
40. 10.1021/acs.molpharmaceut.6b0083910.1021/acs.molpharmaceut.6b00839 ↗
41. 10.1021/acs.nanolett.6b0426910.1021/acs.nanolett.6b04269 ↗
42. 10.1074/jbc.TM118.00333710.1074/jbc.TM118.003337 ↗
43. 10.1016/j.febslet.2007.11.01810.1016/j.febslet.2007.11.018 ↗
44. 10.1007/BF0340175610.1007/BF03401756 ↗
45. 10.1074/jbc.M60953220010.1074/jbc.M609532200 ↗
46. 10.1021/acs.accounts.1c0021510.1021/acs.accounts.1c00215 ↗
47. 10.1074/jbc.M109.08079610.1074/jbc.M109.080796 ↗
48. 10.4161/auto.460010.4161/auto.4600 ↗
49. 10.4161/auto.2734410.4161/auto.27344 ↗
50. 10.3791/6068210.3791/60682 ↗
51. 10.1080/15548627.2018.153529210.1080/15548627.2018.1535292 ↗
52. 10.1523/JNEUROSCI.22-21-09267.200210.1523/JNEUROSCI.22-21-09267.2002 ↗
53. Constantino S. · Eur. Cytokine Network · 2001 · 12 · 365
54. 10.1080/15548627.2018.147431410.1080/15548627.2018.1474314 ↗